The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1576
ISSUE1576
July 15, 2019
Drugs for Smoking Cessation
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Drugs for Smoking Cessation
July 15, 2019 (Issue: 1576)
Smoking tobacco remains the primary preventable
cause of death in the US. Smoking cessation often requires
both pharmacotherapy and behavioral support.
- AL Siu et al. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015; 163:622.
- RS Barua et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 2018; 72:3332.
- J Hartmann-Boyce et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 2018; 5:CD000146.
- AC Farley et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2012; 1:CD006219.
- N Lindson et al. Different doses, durations, and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2019; 4:CD013308.
- Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2017 September 18 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
- LA Kroon. Drug interactions with smoking. Am J Health Syst Pharm 2007; 64:1917.
- GD Anderson and LN Chan. Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products. Clin Pharmacokinet 2016; 55:1353.
- JR Hughes et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014; 1:CD000031.
- JT Hays and JO Ebbert. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs 2003; 17:71.
- Varenicline (Chantix) for tobacco dependence. Med Lett Drugs Ther 2006; 48:66.
- EJ Mills et al. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med 2012; 44:588.
- K Cahill et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013; 5:CD009329.
- TB Baker et al. Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial. JAMA 2016; 315:371.
- AS Gershon et al. Cardiovascular and neuropsychiatric events after varenicline use for smoking cessation. Am J Respir Crit Care Med 2018; 197:913.
- D Kotz et al. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study. Lancet Respir Med 2015; 3:761.
- JR Hughes. Varenicline as a cause of suicidal outcomes. Nicotine Tob Res 2016; 18:2.
- RM Anthenelli et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med 2013; 159:390.
- AE Evins et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA 2014; 311:145.
- RM Anthenelli et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016; 387:2507.
- MB Steinberg et al. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med 2009; 150:447.
- CF Koegelenberg et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA 2014; 312:155.
- JO Ebbert et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA 2014; 311:155.
- JE Rose and FM Behm. Combination varenicline/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm. Nicotine Tob Res 2017; 19:999.
- M Siahpush et al. Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. BMJ Open 2015; 5:e006229.
- RA Schnoll et al. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med 2015; 175:504.
- N Lindson-Hawley et al. Gradual reduction vs abrupt cessation as a smoking cessation strategy in smokers who want to quit. JAMA 2013; 310:91.
- N Lindson-Hawley et al. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev 2012; 11:CD008033.
- N Lindson-Hawley et al. Gradual versus abrupt smoking cessation: a randomized, controlled noninferiority trial. Ann Intern Med 2016; 164:585.
- JA Cunningham et al. Effect of mailing nicotine patches on tobacco cessation among adult smokers: a randomized clinical trial. JAMA Intern Med 2016; 176:184.
- EC Donny et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med 2015; 373:1340.
- SD Halpern et al. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med 2018; 378:2302.
- SD Halpern et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med 2015; 372:2108.
- C Bullen et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382:1629.
- P Hajek et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019; 380:629.
- S Kalkhoran and SA Glantz. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4:116.
- J Hartmann-Boyce et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016; 9:CD010216.
- SA Glantz and DW Bareham. E-Cigarettes: use, effects on smoking, risks, and policy implications. Annu Rev Public Health 2018; 39:215.
- T Alzahrani et al. Association between electronic cigarette use and myocardial infarction. Am J Prev Med 2018; 55:455.
- L McCauley et al. An unexpected consequence of electronic cigarette use. Chest 2012; 141:1110.
- JL Barrington-Trimis et al. E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics 2016; 138:e20153983.
- ML Goniewicz et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open 2018, 1:e185937.
- M Sleiman et al. Emissions from electronic cigarettes: key parameters affecting the release of harmful chemicals. Environ Sci Technol 2016; 50:9644.
- R Goel et al. Highly reactive free radicals in electronic cigarette aerosols. Chem Res Toxicol 2015; 28:1675.
- L Kosmider et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16:1319.
- ML Goniewicz et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23:133.
- A Ghosh et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med 2018; 198:67.
- B Reidel et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 2018; 197:492.
- WH Lee et al. Modeling cardiovascular risks of e-cigarettes with human-induced pluripotent stem cell-derived endothelial cells. J Am Coll Cardiol 2019; 73:2722.
- T Coleman et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015; 12:CD010078.
- CDC. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Available at: https://www.cdc.gov/ tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed November 20, 2019.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Smoking Cessation
Article code: 1576a
Article code: 1576a
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.